RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV

BACKGROUND: Despite obvious advances over the last decades, locally advanced adenocarcinomas of the gastroesophageal junction (GEJ) still carry a dismal prognosis with overall 5-year survival rates of less than 50% even when using modern optimized treatment protocols such as perioperative chemothera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Lorenzen, Sylvie, Biederstädt, Alexander, Ronellenfitsch, Ulrich, Reißfelder, Christoph, Mönig, Stefan, Wenz, Frederik, Pauligk, Claudia, Walker, Martin, Al-Batran, Salah-Eddin, Haller, Bernhard, Hofheinz, Ralf-Dieter
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7493344/
https://ncbi.nlm.nih.gov/pubmed/32933498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07388-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados